Premium
Biodegradable Copper‐Based Nanoparticles Augmented Chemodynamic Therapy through Deep Penetration and Suppressing Antioxidant Activity in Tumors
Author(s) -
Zheng Runxiao,
Cheng Yan,
Qi Fan,
Wu Yunyun,
Han Xiaoqing,
Yan Jiao,
Zhang Haiyuan
Publication year - 2021
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202100412
Subject(s) - glutathione , hydrogen peroxide , in vivo , antioxidant , chemistry , heme oxygenase , hydroxyl radical , nanoparticle , tumor microenvironment , in vitro , penetration (warfare) , immune system , biophysics , cancer research , materials science , heme , biochemistry , nanotechnology , biology , immunology , enzyme , microbiology and biotechnology , operations research , engineering
Chemodynamic therapy (CDT) efficacy has been limited by the poor penetration ability of large nanoparticles (NPs) and the antioxidant activity of tumors, especially high heme oxygenase (HO‐1) and glutathione (GSH) levels. Herein, PEGylated CuMoO x ‐coated and zinc protoporphyrin IX (ZP)‐loaded Cu (CCMZ) NPs are designed to afford rapid degradation ability and augmented CDT efficacy through inhibiting HO‐1 activity and depleting GSH. The deep penetration of tumor can be achieved under the high levels of GSH, which triggers the degradation of CuMoO x shell. Meanwhile, GSH itself is depleted, which converts the reductive environment into constant oxidative environment, thus leading to the degradation of Cu core. Furthermore, the release of ZP from CCMZ NPs can inhibit HO‐1 activity and provide a favorable microenvironment for CDT, and the release of Cu and Mo ions can convert hydrogen peroxide into hydroxyl radical to eliminate tumor cells more efficiently. In addition, CCMZ NPs also play an immune vaccine‐like effect to recruit different immune cells for antitumor immunotherapy. In vitro and in vivo studies prove the augmented CDT property of CCMZ NPs, supplying a new strategy for improving CDT efficacy.